Ocular Therapeutix, Inc. Comparables
Find the most relevant public market comparables for Ocular Therapeutix, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for eye diseases and conditions using its proprietary hydrogel platform technology. The company's products aim to overcome limitations of current eye-drop based therapies.
Business Model
Development and commercialization of innovative therapies for eye diseases and conditions using a proprietary hydrogel platform technology.
Target Customers
Ophthalmologists, patients with various eye diseases and conditions.
Specific Focus
Sustained-release drug delivery for ophthalmic diseases
Location
Bedford, Massachusetts
CEO
Pravin U. Dugel
Industry
Life sciences
Sub Sector
Ophthalmic Biopharmaceuticals
3yr Revenue Growth
236%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Ocular Therapeutix, Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Ocular Therapeutix, Inc.? Our platform provides detailed analysis of Ocular Therapeutix, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Ocular Therapeutix, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Ocular Therapeutix, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Ocular Therapeutix, Inc. operates in the specialized Ophthalmic Biopharmaceuticals sub-sector. Understanding how Ocular Therapeutix, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Ophthalmic Biopharmaceuticals space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Ocular Therapeutix, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free